Brief: Chromadex Finalizes Commercial Joint-Venture In Asia And Announces $3.1 Million Private Placement Of Common Stock
03/10/2022 12:38
Oct 3 (Reuters) - Chromadex Corp CDXC.O :
* CHROMADEX FINALIZES COMMERCIAL JOINT-VENTURE IN ASIA AND
ANNOUNCES $3.1 MILLION PRIVATE PLACEMENT OF COMMON STOCK
Source text for Eikon: ID:nBw2p9h6ba
Further company coverage: CDXC.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Niagen Bioscience
See all newsAs weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Niagen Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Niagen Bioscience Q2 net sales fall, missing estimates
Niagen Bioscience Inc expected to post earnings of 2 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce